MedPath

Bupivacaine

Generic Name
Bupivacaine
Brand Names
Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
Drug Type
Small Molecule
Chemical Formula
C18H28N2O
CAS Number
38396-39-3
Unique Ingredient Identifier
Y8335394RO
Background

Bupivacaine is a widely used local anesthetic agent.

Indication

As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.

Bupivacaine, in liposome suspension, is indicated in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia. In adults, it is also indicated as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.

Bupivacaine, in combination with meloxicam, is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.

Bupivacaine, alone or in combination with epinephrine, is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Finally, its use is not indicated in all blocks given clinically significant risks associated with use.

Associated Conditions
Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
Associated Therapies
General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy

Neurotoxicity of Spinal Anesthesia With Ropivacaine and Bupivacaine

Phase 4
Conditions
Anaesthetic Complication Neurological
Anesthesia; Adverse Effect, Spinal and Epidural
Interventions
First Posted Date
2017-09-26
Last Posted Date
2017-12-18
Lead Sponsor
University of Rzeszow
Target Recruit Count
60
Registration Number
NCT03293472
Locations
🇵🇱

University of Rzeszow, Rzeszów, Poland

Randomized Controlled Trial for Exparel Hip Fracture

Phase 4
Completed
Conditions
Hip Fractures
Interventions
First Posted Date
2017-09-21
Last Posted Date
2021-03-18
Lead Sponsor
University of Massachusetts, Worcester
Target Recruit Count
55
Registration Number
NCT03289858
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

🇺🇸

UMass Memorial Medical Center, Worcester, Massachusetts, United States

Interscalene Block Versus Superior Trunk Block

Phase 4
Completed
Conditions
Joint Disease
Pain, Acute
Pain
Pain, Chronic
Interventions
Drug: Bupivacaine
Device: Ultrasound
First Posted Date
2017-09-05
Last Posted Date
2022-05-11
Lead Sponsor
Hospital for Special Surgery, New York
Target Recruit Count
126
Registration Number
NCT03272139
Locations
🇺🇸

Hospital for Special Surgery, New York, New York, United States

Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride

Phase 3
Completed
Conditions
Coronary Artery Stenoses
Valve Regurgitation, Tricuspid
Coronary Artery Disease
Valve Regurgitation, Mitral
Interventions
First Posted Date
2017-09-01
Last Posted Date
2021-09-05
Lead Sponsor
Kathirvel Subramaniam
Target Recruit Count
60
Registration Number
NCT03270514
Locations
🇺🇸

UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States

Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation

Phase 4
Withdrawn
Conditions
Atrial Fibrillation
Interventions
Other: Saline
Drug: Bupivacaine
First Posted Date
2017-08-31
Last Posted Date
2019-04-24
Lead Sponsor
Christopher Connors, MD
Registration Number
NCT03269383
Locations
🇺🇸

Maine Medical Center, Portland, Maine, United States

Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?

Completed
Conditions
Pelvic Organ Prolapse
Postoperative Pain
Interventions
First Posted Date
2017-08-30
Last Posted Date
2019-08-08
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
140
Registration Number
NCT03266926
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Adding Ketamine to Low Dose Bupivacaine in Saddle Block for Perianal Surgery

Early Phase 1
Conditions
Perianal Fistula
Hemorrhoids
Interventions
First Posted Date
2017-08-29
Last Posted Date
2018-01-17
Lead Sponsor
Esam Eldin Mohamed Abdalla
Target Recruit Count
60
Registration Number
NCT03264430

Caudal Combination of Dexamethasone and/or Dexmedetomidine to Bupivacaine in Pediatric Hypospadias Surgery

Phase 1
Completed
Conditions
Caudal Block
Interventions
First Posted Date
2017-08-25
Last Posted Date
2017-08-25
Lead Sponsor
Cairo University
Target Recruit Count
63
Registration Number
NCT03261921

Comparison of Efficacy of Bupivacaine for Relief Postoperative Pain in Women Undergoing Laparoscopic Gynecologic Surgery

Phase 4
Completed
Conditions
Postoperative Pain Score
Interventions
First Posted Date
2017-08-23
Last Posted Date
2020-10-22
Lead Sponsor
Rajavithi Hospital
Target Recruit Count
100
Registration Number
NCT03259243
Locations
🇹🇭

Waetasleem Chema, Bangkok, Thailand

Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy

Phase 4
Completed
Conditions
Hysterectomy
Interventions
Drug: Bupivacaine
Drug: Liposomal bupivacaine
Drug: Saline
First Posted Date
2017-08-15
Last Posted Date
2022-12-21
Lead Sponsor
Henry Ford Health System
Target Recruit Count
90
Registration Number
NCT03250507
Locations
🇺🇸

Henry Ford Hospital, Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath